LMAT — LEMAITRE VASCULAR INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1158895 ·
Last close
$76.10
Market Cap
$1.74B
52W High
$117.37
52W Low
$75.67
ADV30
275,767
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 67,970,000 | 48,705,000 | 17,695,000 | 15,024,000 | 656,032,000 | 27,493,000 | 223,901,000 |
| Jun 2026 | 70,382,000 | 50,764,000 | 20,399,000 | 17,050,000 | 640,549,000 | 26,625,000 | 220,207,000 |
| Mar 2026 | 66,551,000 | 48,396,000 | 17,775,000 | 15,679,000 | 629,526,000 | 26,851,000 | 222,904,000 |
| Dec 2025 | 64,453,000 | 46,190,000 | 18,832,000 | 15,582,000 | 615,690,000 | 28,244,000 | 222,174,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$76,205,000
Investing CF
$-57,234,000
Financing CF
$-16,830,000
CapEx
$-9,206,000
Dividends Paid
$-21,681,000
Buybacks
—
EPS Diluted TTM
$2.75
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$215,324,000
Inventory
$57,075,000
Receivables
$35,876,000
ST Investments
$362,228,000
EBIT TTM
$87,039,000
Pretax Income TTM
$81,835,000
Interest Exp TTM
$5,204,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$269,356,000
EBITDA
$79,976,000
Free Cash Flow
$44,726,124
Enterprise Value
$1,649,963,648
Total Cash
$389,720,992
Total Debt
$188,851,008
Shares Out
22,880,871
Trailing EPS
$2.75
Book Value
$18.89
ROE
15.6%
ROA
6.9%
Div Yield
1.23%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 249,602,000 | 67,912,000 | 57,734,000 | 615,690,000 | 222,174,000 | 393,516,000 | 81,251,000 |
| Dec 2024 | 219,863,000 | 52,256,000 | 44,038,000 | 551,817,000 | 214,527,000 | 337,290,000 | 44,124,000 |
| Dec 2023 | 193,484,000 | 37,197,000 | 30,105,000 | 346,778,000 | 48,878,000 | 297,900,000 | 36,751,000 |
| Dec 2022 | 161,651,000 | 29,936,000 | 20,636,000 | 310,476,000 | 42,275,000 | 268,201,000 | 25,378,000 |
TTM Snapshot
Revenues TTM
$262,432,000
NetIncome TTM
$65,673,000
OpCashFlow TTM
—
Assets (Latest)
$640,549,000
Forward EPS
$3.17
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $75.00 · spot: $75.58 · call volume: 31 · put volume: 12
Expected Move to 2026-12-18:
±$5.50
(7.28%) —
implied range
$70.08 –
$81.08
· ATM straddle on $75.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INSP | Inspire Medical Systems, Inc. | $1.72B | $59.41 | — |
| XRAY | DENTSPLY SIRONA Inc. | $1.71B | $8.60 | — |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.66B | $28.27 | — |
| ENOV | Enovis CORP | $1.57B | $27.22 | — |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $2.07B | $69.51 | — |
News headlines (Yahoo Finance, 1h cache)
Does LeMaitre Vascular (LMAT) Trade At A Premium To Cash Flow?
2026-11-08 06:12 · Yahoo
LeMaitre Vascular (LMAT) Shares Dropped, So What Is Driving Attention Now?
2026-11-08 05:17 · Yahoo
Earnings Guidance Lift Might Change The Case For Investing In LeMaitre Vascular (LMAT)
2026-11-08 02:16 · Yahoo
LeMaitre Vascular (LMAT) Acquires Vascular Assets To Expand Outside North America
2026-11-07 18:13 · Yahoo
LeMaitre to Participate in Upcoming Investor Conferences
2026-11-06 21:05 · Yahoo
LeMaitre Vascular (LMAT) Q3 2026 Earnings Call Transcript
2026-11-05 19:46 · Yahoo
LeMaitre Vascular, Inc. Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
LeMaitre Vascular Inc (LMAT) (Q3 2026) Earnings Call Highlights: 12% Organic Growth, B. ...
2026-11-05 11:10 · Yahoo
LeMaitre Vascular Q3 Earnings Call Highlights
2026-11-05 03:14 · Yahoo
LeMaitre Vascular (LMAT) Misses Q3 Earnings Estimates
2026-11-04 23:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.